File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Effects of induced pluripotent stem cell and bone marrow-derived mesenchymal stem cells on cigarette smoke-induced lung damage in rats

TitleEffects of induced pluripotent stem cell and bone marrow-derived mesenchymal stem cells on cigarette smoke-induced lung damage in rats
Authors
KeywordsMedical sciences
Respiratory diseases
Issue Date2013
PublisherAmerican Thoracic Society. The Conference Abstracts' web site is located at http://www.atsjournals.org/series/ajrccm-conference
Citation
The 2013 International Conference of the American Thoracic Society (ATS), Philadelphia, PA., 17-22 May 2013. In American Thoracic Society International Conference Abstracts, 2013, v. 187, p. A4850 How to Cite?
AbstractRATIONALE: Cigarette smoking (CS) is the major cause of chronic obstructive pulmonary disease (COPD) which is the fourth leading cause of death and predicted to be the third by 2030. Administration of bone marrow-derived mesenchymal stem cells (BM-MSC) was reported to attenuate CS-induced emphysema in murine model. This study aimed to investigate the effects of induced pluripotent stem cell derived-MSC (IPSC-MSC) on CS-induced lung damage in comparison to BM-MSC treatment in rats. METHODS: Male Sprague-Dawley rats were randomly divided into four groups. The sham air (SA) group was exposed to fresh air while the other three groups to 4% cigarette smoke (CS) one hour per day for 56 days. During the second half of the smoking period, two doses of 3x106 of IPSC-MSC or BM-MSC cells were injected intravenously via tail vein to the two groups, i.e. IP/CS group or BM/CS group at day 29 and day 43. The SA and CS group were injected with phosphate-buffered saline of the same volume. All rats were sacrificed 24 hours after the last CS exposure. Morphological changes were examined in paraffin-embedded lung sections. Levels of inflammatory markers were measured by ELISA. RESULTS: Both IPSC-MSC and BM-MSC were able to reside in the lung for as long as 14 days with significant higher density of resided IPSC-MSCs. Both treatments shared similar efficacy to attenuate CS-induced lung cell apoptosis, to restore CS-induced reduction of lung IL-10 and to alleviate CS-induced elevation of systemic TGF-β1. CONCLUSION: Our findings suggest that treatment of IPSC-MSC or BM-MSC might be able to slow down CS-induced disease progression, possibly through anti-oxidant, anti-inflammatory and anti-apoptotic properties.
DescriptionC75 Animal Models of Emphysema - Thematic Poster Session
The American Journal of Respiratory and Critical Care Medicine contain American Thoracic Society International Conference Abstracts
Persistent Identifierhttp://hdl.handle.net/10722/204294
ISSN
2015 Impact Factor: 13.118
2015 SCImago Journal Rankings: 5.832

 

DC FieldValueLanguage
dc.contributor.authorLi, Xen_US
dc.contributor.authorZhang, Yen_US
dc.contributor.authorYeung, SCen_US
dc.contributor.authorLian, Qen_US
dc.contributor.authorTse, HFen_US
dc.contributor.authorIp, MSMen_US
dc.contributor.authorMak, JCWen_US
dc.date.accessioned2014-09-19T21:43:25Z-
dc.date.available2014-09-19T21:43:25Z-
dc.date.issued2013en_US
dc.identifier.citationThe 2013 International Conference of the American Thoracic Society (ATS), Philadelphia, PA., 17-22 May 2013. In American Thoracic Society International Conference Abstracts, 2013, v. 187, p. A4850en_US
dc.identifier.issn1073-449X-
dc.identifier.urihttp://hdl.handle.net/10722/204294-
dc.descriptionC75 Animal Models of Emphysema - Thematic Poster Session-
dc.descriptionThe American Journal of Respiratory and Critical Care Medicine contain American Thoracic Society International Conference Abstracts-
dc.description.abstractRATIONALE: Cigarette smoking (CS) is the major cause of chronic obstructive pulmonary disease (COPD) which is the fourth leading cause of death and predicted to be the third by 2030. Administration of bone marrow-derived mesenchymal stem cells (BM-MSC) was reported to attenuate CS-induced emphysema in murine model. This study aimed to investigate the effects of induced pluripotent stem cell derived-MSC (IPSC-MSC) on CS-induced lung damage in comparison to BM-MSC treatment in rats. METHODS: Male Sprague-Dawley rats were randomly divided into four groups. The sham air (SA) group was exposed to fresh air while the other three groups to 4% cigarette smoke (CS) one hour per day for 56 days. During the second half of the smoking period, two doses of 3x106 of IPSC-MSC or BM-MSC cells were injected intravenously via tail vein to the two groups, i.e. IP/CS group or BM/CS group at day 29 and day 43. The SA and CS group were injected with phosphate-buffered saline of the same volume. All rats were sacrificed 24 hours after the last CS exposure. Morphological changes were examined in paraffin-embedded lung sections. Levels of inflammatory markers were measured by ELISA. RESULTS: Both IPSC-MSC and BM-MSC were able to reside in the lung for as long as 14 days with significant higher density of resided IPSC-MSCs. Both treatments shared similar efficacy to attenuate CS-induced lung cell apoptosis, to restore CS-induced reduction of lung IL-10 and to alleviate CS-induced elevation of systemic TGF-β1. CONCLUSION: Our findings suggest that treatment of IPSC-MSC or BM-MSC might be able to slow down CS-induced disease progression, possibly through anti-oxidant, anti-inflammatory and anti-apoptotic properties.-
dc.languageengen_US
dc.publisherAmerican Thoracic Society. The Conference Abstracts' web site is located at http://www.atsjournals.org/series/ajrccm-conference-
dc.relation.ispartofAmerican Thoracic Society International Conference Abstractsen_US
dc.subjectMedical sciences-
dc.subjectRespiratory diseases-
dc.titleEffects of induced pluripotent stem cell and bone marrow-derived mesenchymal stem cells on cigarette smoke-induced lung damage in ratsen_US
dc.typeConference_Paperen_US
dc.identifier.emailLi, X: lixiaomu@hku.hken_US
dc.identifier.emailYeung, SC: flag@hkucc.hku.hken_US
dc.identifier.emailLian, Q: qzlian@hkucc.hku.hken_US
dc.identifier.emailTse, HF: hftse@hkucc.hku.hken_US
dc.identifier.emailIp, MSM: msmip@hku.hken_US
dc.identifier.emailMak, JCW: judithmak@hku.hken_US
dc.identifier.authorityLian, Q=rp00267en_US
dc.identifier.authorityTse, HF=rp00428en_US
dc.identifier.authorityIp, MSM=rp00347en_US
dc.identifier.authorityMak, JCW=rp00352en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros239199en_US
dc.identifier.volume187en_US
dc.identifier.spageA4850en_US
dc.identifier.epageA4850en_US
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats